Project Grant G11AI183351
Award Date
9/1/24
Completion Date
2/28/26
Dollars Obligated
$245K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pakistan
Similar Awards
The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...
This Project Grant award of $146,170 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a global framework to grow interdisciplinary research at the University of Virginia (UVA). The project aims to primarily assist junior faculty engaged in global health research with developing funding and interdisciplinary collaborations. Key activities include mentoring, building scientific methodology expertise, and leadership...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $212,169 to The Johns Hopkins University to advance mentorship and research capabilities related to combating antimicrobial resistant (AMR) infections. The award will enable the principal investigator to enhance their expertise in constructing site-directed mutants of key β-lactamase enzymes and integrating...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to comprehensively investigate the extent and impact of transmitted and acquired HIV drug resistance in Kenya as the country transitions to widespread use of dolutegravir-based antiretroviral therapy. The $645,900 award, with a project period from September 2024 to July 2029, will fund a prospective study to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $430,285.00 to Towson University to investigate RTA-induced ubiquitination in Kaposi's Sarcoma Herpesvirus (KSHV) and identify potential cellular targets and small molecule inhibitors for intervention. The 3-year project aims to evaluate the impact of RTA target modification/degradation on KSHV latency...
This Project Grant award of $1,454,386.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports fundamental research to better understand the epigenetic regulation of the HIV-1 viral RNA cap. The research aims to define the structural basis of HIV cap hypermethylation and its linkage to modulating host innate immune signaling, with the goal of developing new treatments to neutralize deleterious...
This $153,056 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Washington University will support research to investigate heme homeostasis mechanisms in the malaria parasite Plasmodium falciparum. The research aims to identify parasite heme-binding proteins and assess their essentiality for parasite viability, as well as investigate the role of the heme detoxification protein PfHDP in parasite...
This Project Grant award of $1,246,486 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports the "ACCELERATING PUBLIC HEALTH IMPACT THROUGH THE UNIVERSITY OF WASHINGTON/NASTAD RESEARCH ALLIANCE IN IMPLEMENTATION SCIENCE TO END HIV (RAISE) REGIONAL CONSULTATIVE HUB" to enhance the impact of the Ending the HIV Epidemic (EHE) initiative. The key products and services to be delivered under this award include:...
This Project Grant award, totaling $902,964.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant supports research to evaluate mechanisms that restrain or enhance alveolar macrophage (AM) responses to Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, with the goal of understanding the regulation of early events during MTB infection. The key...
This Project Grant award of $375,000.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports a research project to investigate the role of messenger ribonucleoprotein (mRNP) granules in regulating RNA metabolism and translation in the malaria parasite Plasmodium falciparum. The project aims to identify molecular markers for distinct mRNP types, determine their protein and mRNA compositions, and characterize their...